A Phase 1 Study to Evaluate the Pharmacokinetics of Roxadustat in Subjects With Different Degrees of Renal Function
Phase of Trial: Phase I
Latest Information Update: 23 Jun 2017
At a glance
- Drugs Roxadustat (Primary)
- Indications Renal failure
- Focus Pharmacokinetics
- Sponsors Astellas Pharma Europe Ltd
- 04 Apr 2017 Planned End Date changed from 1 Jun 2017 to 1 Sep 2017.
- 04 Apr 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Sep 2017.
- 17 Feb 2017 Status changed from not yet recruiting to recruiting.